Johnson & Johnson将在2026年3月之前停止全球Linx回流装置的销售, Johnson & Johnson will halt global sales of its Linx reflux device by March 2026, citing market reasons, despite no safety issues.

由于市场相关因素,Johnson & Johnson将在2026年3月之前停止在美国境外销售其Linx回流管理系统,尽管该装置在美国仍然可用。 Johnson & Johnson will stop selling its Linx Reflux Management System outside the U.S. by March 2026 due to market-related factors, though the device remains available in the U.S. 该决定没有提及安全问题,但引起了医生的担忧,医生说,它可能伤害病人,特别是等待肺移植的病人,并可能逆转治疗严重酸性回流方面的进展。 The decision, which cites no safety issues, has drawn concern from doctors who say it may harm patients, especially those awaiting lung transplants, and could reverse progress in treating severe acid reflux. Linx装置使用磁珠加强食道螺旋杆,自2007年以来被广泛使用,对传统外科手术有好处。 The Linx device, which uses magnetic beads to strengthen the esophageal sphincter, has been widely used since 2007 and offers benefits over traditional surgery. 虽然欧洲部分地区存在替代装置,但缺乏长期数据和广泛准入。 While a replacement device exists in parts of Europe, it lacks long-term data and broad access. 该公司将继续支持受影响区域的现有病人和提供者。 The company will continue supporting existing patients and providers in affected regions.